AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05492253 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Infant vegetable
Description: Infants will be fed carrot puree
Study NCT05492253 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Infant meat
Description: Infants will be fed beef puree
Study NCT05492253 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Infant grain
Description: Infants will be fed oatmeal cereal
Study NCT05810194 — intervention group
Intervention type: DEVICE
Intervention: StrataXRT
Description: StrataXRT® is a TGA-approved silicone-based topical preparation. StrataXRT is a self-drying, non-sticky, transparent, silicone gel formulation and when used as directed, dries to form an inert, thin, flexible wound dressing with a protective layer that is gas permeable and waterproof. It is the only self-drying topical silicone gel indicated for the use on radiation dermatitis, which hydrates and protects compromised skin areas and open wounds from chemical and microbial invasion. StrataXRT helps create an optimal wound healing environment which leads to faster re-epithelialization and a reduced inflammatory response. The product can be applied to fresh incisions and excisions, open wounds and compromised skin surfaces.
Study NCT05810194 — intervention group
Intervention type: DRUG
Intervention: Calendula
Description: Calendula creams are over-the-counter (OTC) skin care ointments that are non-greasy, non-sticky, and quickly absorbed by the skin. Calendula is a topical agent derived from a plant of the marigold family Calendula Officinalis and is used in cuts, scrapes, chafing and minor burns. Containing numerous polyphenolic antioxidants, calendula has been studied in both the laboratory and clinical setting for the use in treating and preventing radiation induced skin toxicity.
Study NCT06478264 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: 100mg/m\^2, intravenous infusion for 1-3 days,21 days/cycle, 4 cycles
Study NCT06478264 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: 25mg/m\^2 ,intravenous infusion for 1-3 days ,21 days/cycle, 4 cycles
Study NCT06478264 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Carboplatin (AUC = 5) on 1 Day,21 days/cycle, 4 cycles ;
Study NCT06478264 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adebrelimab
Description: 1200mg adebrelimab was given intravenously on 2 day after chemotherapy,21 days/cycle, continuous use.
Study NCT06478264 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiotherapy
Description: Stage I-IVa , prescription dose: PTV 50Gy/25f. Stage IVb ,prescribed dose: PTV 30Gy/10f.
Study NCT06358170 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Circuit Training Combine with Square-Stepping Exercise
Description: Circuit Training Combine with Square-Stepping Exercise
Study NCT04331561 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: sensory re-weighting
Description: Participants will be supported in quiet standing by a safety harness and crisscrossing strap system. A cervical collar will be used to maintain consistent alignment between the head and trunk. A virtual reality headset is used to create a virtual environment in which visual stimuli will be presented. Three different body positions will be used during training: earth-vertical and clockwise and counterclockwise tilted 16º in the frontal plane. Sensory re-weighting will be driven by priming upregulation of somatosensory cues. In each training trial, participants must determine the direction of gravity and then indicate if the rod being displayed is aligned with gravity or if it needs to rotate clockwise or counterclockwise for that to be so. Participants will be instructed to pay attention to what they feel from their feet, legs, and gut during training and to use that pressure, stretch, movement, and muscle tension feedback to help them sense gravity.
Study NCT05810194 — intervention group
Intervention type: DRUG
Intervention: Aquaphor
Description: Aquaphor, containing 41 percent petrolatum (or petroleum jelly), temporarily protects minor cuts, scrapes, and burns; Aquaphor protects and helps relieve chapped or cracked skin and lips, as well as helps protecting from the drying effects of wind and cold weather.
Study NCT06162104 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT04814212 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention using drug-coated balloon
Description: SeQuent Please (BBraun) + tailored antithrombotic regimen:~1. Stable patients without OAC: perioperative SAPT (preferably) or perioperative DAPT followed by lifelong SAPT~2. Stable patients with OAC: perioperative SAPT (preferably) or perioperative DAPT and lifelong OAC~3. ACS patients without OAC: 1-month DAPT followed by lifelong SAPT~4. ACS patients with OAC: perioperative DAPT followed by 1-month SAPT and lifelong OAC
Study NCT04814212 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous coronary intervention using drug-eluting stent
Description: Biofreedom (Biosensors), Synergy (Boston Scientific), Ultimaster Tansei (Terumo) and Integrity Onyx (Medtronic), Xience Pro S (Abbott) or Promus Elite (Boston Scientific) or any other DES can also be used provided that it has a CE mark for 1-month DAPT, combined with tailored antithrombotic regimen:~1. Stable patients without OAC: 1-month DAPT followed by lifelong SAPT~2. Stable patients with OAC: perioperative DAPT followed by 6 months SAPT (ADP receptor blocker) and life-long OAC~3. ACS patients without OAC: 3-month DAPT followed by lifelong SAPT~4. ACS patients with OAC: perioperative DAPT followed by 6 months SAPT (ADP receptor blocker) and lifelong OAC
Study NCT05418530 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: with pause- without pause
Description: start with pause expiration
Study NCT05418530 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: without pause-with pause
Description: start without pause expiration
Study NCT05402007 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Pulmonary rehabilitation exercises at the Rehabilitation Center
Description: Face-to-face intervention (12 weeks): Using the participants' assessment and personal characteristics, the therapist will prescribe pulmonary rehabilitation exercises that will be performed at the pulmonary rehabilitation center.
Study NCT05402007 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Home Intervention
Description: Home Intervention (12 weeks): Using the participants' assessment and personal characteristics, the therapist will provide a portfolio of self-explanatory exercises, and guide participants on safety precautions.
Study NCT05242835 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard duodenal switch
Description: Standard duodenal switch as second stage surgery after a sleeve gastrectomy (100cm common channel and 150cm alimentary limb)
Study NCT05242835 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single-anastomosis duodenal switch
Description: Single-anastomosis duodeno-ileal anastomosis as second stage surgery after a sleeve gastrectomy (250cm common channel)
Study NCT04730310 — intervention group
Intervention type: PROCEDURE
Intervention: NSQIP Lower Extremity Open (LEO) procedure-targeted dataset (i.e. undergoing Lower extremity open revascularization) from 2014-2019
Description: Infrainguinal, open lower extremity revascularization procedures
Study NCT05382962 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: iCanCope Post Op Application
Description: The iCanCope program is designed to enhance pain self-management and self-efficacy, defined as perception of one's ability to successfully produce a desired effect in a task or behavior affecting their life. The intervention will be delivered on the iOS or Android smartphone platform depending on the participant's device. Usage of app features will be centrally tracked by the research team using Analytics Platform to Evaluate Effective Engagement (APEEE), developed at the Centre for Global eHealth Innovation. Participants will receive alerts through iCanCope to complete a pain diary check-in once per week preoperatively, twice per day over the initial 2-week postoperative period, and once per day for the subsequent 2-week period.
Study NCT04824222 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Human fecal microbiota, MBiotix HBI
Description: The FMT will be administered orally in double cover, gastro-resistant, enteric release capsules in 60g dose (about 30-50 frozen capsules).
Study NCT04824222 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Double cover, gastro-resistant, enteric release capsules with lactose (about 30-50 frozen capsules)
Study NCT04824222 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SOC
Description: The standard COVID 19 pharmacological treatment
Study NCT04824222 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: SOC
Description: The standard COVID 19 pharmacological treatment
Study NCT05921591 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IRL201104
Description: Lyophilised powder for reconstitution for IV dosing
Study NCT05921591 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching placebo for IRL201104
Study NCT06011317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EDG-7500
Description: EDG-7500 is administered orally once daily
Study NCT06011317 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Placebo is administered orally once daily
Study NCT05757180 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive Events Training (PET)
Description: PET is a group-based training program combining Memory Specificity Training (MEST; Raes, 2007) and Future Event Specificity Training (FEST; Dutch version of Hallford et al. (2020): Changing the Future: An initial test of Future Specificity Training). It comprises four sessions of 50 minutes each. The training is delivered in a standardized manner, using the Positive Event Training Manual developed for this study (content adapted from our MEST and FEST manuals). Following brief psychoeducation on the rationale, participants practice generating detailed specific memories and future events using neutral and positive cue-words. Participants are maximally supported and challenged by the trainer and by the other group-members to generate very specific and highly detailed memories and future events using mental imagery and drawing upon visual, olfactory, auditory and emotional elements of the events, including both contextual and sensory-perceptual details.
Study NCT05757180 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CREAtive writing Training (CREAT)
Description: CREAT follows the exact same format and length as the PET training (i.e., delivered by a trainer in group over 4 x 50-minute sessions, including homework exercises). Following brief psychoeducation on the (bogus\*) rationale behind PET, participants complete a series of creative writing exercises using funny and thought-provoking writing prompts. Just as in PET, participants are maximally supported and challenged by the trainer and by the other group-members, in this case to generate completions that are as creative and funny as possible. The investigators used CREAT successfully before in an online format as a bogus control training for a memory specificity training. (\*) The investigators tell participants that these creative writing exercises have been found to be beneficial for mental wellbeing, as creative writing exercises cultivate creativity and stimulate participants' imagination skills.
Study NCT05985798 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sin-Bev-TACE
Description: Sintilimab (200mg I.V. q3w) and bevacizumab (7.5mg/kg I.V. q3w) are administered at 3-7 days after the first TACE. The study treatment of sintilimab and bevacizumab will last up to 24 months. TACE can be repeated on demand.
Study NCT05985798 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Len-TACE
Description: Lenvatinib 12mg (body weight ≥60kg) or 8mg (body weight \<60kg) P.O. qd will be started at 3-7 days after the first TACE. TACE will be repeated on demand.
Study NCT05957458 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Airdoc device of red light for Myopia
Description: This light is Narrow-Band, Long-Wavelength Lighting with three different illumination (400lux, 800lux, 1200lux) or irridiance (1.2mW, 0.6mW, 0.37mW) respectively. And the wavelength is 650nm. It allows biocular therapy.
Study NCT05957458 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Airdoc device of red light for Myopia
Description: This light is Narrow-Band, Long-Wavelength Lighting with three different illumination (400lux, 800lux, 1200lux) or irridiance (1.2mW, 0.6mW, 0.37mW) respectively. And the wavelength is 650nm. It allows biocular therapy.
Study NCT05490277 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Active Vibrotactile coordinated reset
Description: Participants will receive active vibrotactile coordinated reset (vCR) which sends gentle vibrations to the fingertips at a specific pattern. The purpose of the intervention is to test the efficacy of active vCR in comparison to sham vCR.
Study NCT05490277 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham vibrotactile coordinated reset
Description: Participants will receive sham vibrotactile coordinated reset (vCR) which sends gentle vibrations to the fingertips at a specific pattern. The purpose of the intervention is to test the efficacy of active vCR in comparison to sham vCR.
Study NCT05231850 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: All eligible patients receive received 200 mg Tislelizumab intravenously every 3 weeks until disease progression, unacceptable adverse events (AEs) or withdrawal of consent.
Study NCT05016193 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Axem Home Prototype Device
Description: The Axem Home prototype device is a rehabilitation system designed to be used independently by a stroke survivor to facilitate physical rehabilitation exercises in their home environment. The device uses a functional near-infrared spectroscopy (fNIRS) headband that measures the hemodynamic response to rehabilitation exercises and displays this brain activity information to the user.
Study NCT05016193 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Rehabilitation Exercise Program
Description: Individual exercise program prescribed by a therapist in the Early Supported Discharge Program.
Study NCT05016193 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Rehabilitation Exercise Program
Description: Individual exercise program prescribed by a therapist in the Early Supported Discharge Program.
Study NCT05357092 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Appliance. Orthodontic appliance to carry out dentoalveolar movement
Description: A digital 3D model obtained with a 3D scanner: (T1,baseline), (T2, aprox 8 weeks), and at the end of othopedic treatment previous to primary lip surgery (T3, aprox 16 weeks).~Once a week, clinical check.
Study NCT01026155 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Respiratory muscle training
Description: Respiratory muscle endurance training by means of isocapnic voluntary hyperpnoea
Study NCT01026155 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Respiratory muscle training
Description: Respiratory muscle endurance training by means of isocapnic voluntary hyperpnoea
Study NCT05012332 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Erector Spinae Plane Block
Description: All volunteers receive an Erector Spinae Plane Block and an MRI.
Study NCT06434077 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GcMAF injections (100 ng)
Description: The GcMAF 100 ng (Gc protein macrophage-activating factor) will be injected subcutaneously.
Study NCT06434077 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: the placebo solution will be injected subcutaneously 100 ng.
Study NCT04792775 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PE+ER
Description: PE includes the following components: a) psychoeducation about the common reactions to traumatic events and presentation of the treatment rationale b) repeated in vivo exposure to traumatic stimuli, c) repeated, prolonged, imaginal exposure to traumatic memories, and d) relapse prevention strategies and further treatment planning (session 12). DBT Emotion Regulation Skills is integrated as part of this intervention. DBT training provides skills to understand, name, experience and tolerate emotions, as well as skills to change negative emotional responses and to reduce vulnerability to emotion dysregulation (Linehan et al., 2015). The current project includes an adapted 3- session individual emotion regulation skills training intervention to be implemented concurrently with PE which consists of initial teaching/instruction and brief skills review for the remainder of PE treatment.
Study NCT05517616 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: [14C ]APG-2575
Description: orally, single dose of 400 mg / 200 μCi \[14C\] APG-2575
Study NCT05629455 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CareSuperb COVID-19 Antigen Home Test Kit
Description: At home COVID-19 antigen test kit
Study NCT06486766 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Norwegian SMS
Description: Individuals receive a SMS in Norwegian language at the start of the influenza season, to remind them they are recommended to get the influenza vaccine. This intervention arm is applicable to all three populations (general population, immigrants born in Poland, immigrants born in Ukraine)
Study NCT06486766 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Polish/Ukrainian SMS
Description: Individuals receive an SMS in the official language of their native country (i.e., Polish or Ukrainian) at the start of the influenza season, to remind them they are recommended to get the influenza vaccine. This intervention arm is only applicable to the two immigrant populations (immigrants born in Poland, immigrants born in Ukraine)
Study NCT04855630 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: DREEM 2 Headband
Description: Participants will wear the DREEM 2 headband for 3 months for a minimum of 4 out of 7 nights per week and will participate in its digital therapeutic Cognitive Behavioral Therapy - Insomnia (CBT-I) intervention (entails brain stimulation to improve slow wave sleep and sleep hygiene counseling tips to improve sleep behaviors).
Study NCT04855630 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DREEM 2 Headband
Description: Participants will wear the DREEM 2 headband for 3 months for a minimum of 4 out of 7 nights per week and will participate in its digital therapeutic Cognitive Behavioral Therapy - Insomnia (CBT-I) intervention (entails brain stimulation to improve slow wave sleep and sleep hygiene counseling tips to improve sleep behaviors).
Study NCT04855630 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise Routine
Description: Participants will partake in a guided exercise routine. Each routine consists of 30-minute mild circuit training session twice per week for 3 months.
Study NCT05533632 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: Participants will receive semaglutide s.c. injection once weekly in a dose escalation manner for 24 weeks.
Study NCT04132414 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: NIRS open
Description: Treatment according to protocol in phases of cerebral hypoxia.
Study NCT04711239 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: PGT-A / niPGT-A
Description: PGT-A and niPGT-A will be performed using next generation sequencing (NGS) analysis for chromosome copy number variation (CNV). Embryo transfers will rely solely on the results of PGT-A for trophectoderm biopsies.
Study NCT05913492 — intervention group
Intervention type: BEHAVIORAL
Intervention: Simulation training
Description: Each volunteer went through two simulation scenarios of difficult airway management: 1) cannot intubate, can ventilate (CI), 2) cannot intubate, cannot ventilate (CICV) with the assistance of the training centre operator. Following the first simulation round, volunteers were trained on the same day in difficult airway management according to DAS guidelines, using the same equipment as during the simulation. The participants repeated the simulation scenarios immediately after the training and six months later.
Study NCT05963594 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Oligomalt
Description: The investigational product (Oligomalt) dissolved in 300 ml water will be consumed over approximately 10 minutes in the morning of the study visit after a fasting period of at least 10 hours.
Study NCT06275828 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: slow beat mesic listening by headphone
Description: classic slow beat type from researcher
Study NCT05002933 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/ml
Description: Solution for injection Subcutaneous injection
Study NCT04728906 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Heart patch seeded with autologous cardiomyocytes and amnion epithelial stem cells
Description: heart patch is seeded with patient's cardiomyocytes (taken from patient's heart waste tissue when undergoing bypass surgery) and stock amnion epithelial stem cells (HLA-DR negative to eliminate risk of rejection)
Study NCT05963594 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: maltodextrin
Description: The investigational product (maltodextrin) dissolved in 300 ml water will be consumed over approximately 10 minutes in the morning of the study visit after a fasting period of at least 10 hours.